Actionable news
0
All posts from Actionable news
Actionable news in PCRX: Pacira Pharmaceuticals, Inc.,

Top-Ranked Analyst Now Says Sell Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Buy Pacira Pharmaceuticals Inc (PCRX)

Investors who listened to Irina Rivkind Koffler over the past year have made 17 percent on their Koffler bets, according to TipRanks. The analyst, who works for Mizuho Securities, on Wednesday changed her recommendation on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares to Underperform from Neutral, while reiterating a Buy rating on Pacira Pharmaceuticals Inc (NASDAQ:PCRX).

Valeant Pharmaceuticals Intl Inc

Koffler is out with another bearish report on Valeant as she believes the company’s current risk/reward is unfavorable due to growth challenges, 2017 guidance risk, legal overhangs, and weaker asset divestitures. As such, the analyst downgraded the stock to Underperform, while slashing the price target to $11 (from $25), which represents a potential...


More